These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28231368)

  • 21. Malignant Otitis Externa: A persistent challenge.
    Khribi M; El Abed W; Gnaba K
    Tunis Med; 2024 Aug; 102(8):478-482. PubMed ID: 39129575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin in the treatment of malignant external otitis.
    Gehanno P
    Chemotherapy; 1994; 40 Suppl 1():35-40. PubMed ID: 7805430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of gallium-67 in the assessment of response to antibiotic therapy in malignant otitis externa--a case report.
    Paramsothy M; Khanijow V; Ong TO
    Singapore Med J; 1997 Aug; 38(8):347-9. PubMed ID: 9364890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic treatment of Pseudomonas aeruginosa-induced ear canal disease].
    Federspil P
    Laryngorhinootologie; 1993 Mar; 72(3):158. PubMed ID: 8471101
    [No Abstract]   [Full Text] [Related]  

  • 25. Management and Clinical Outcomes of 37 Patients with Necrotizing Otitis Externa: Retrospective Review of a Standardized 6-Week Treatment Pathway.
    Dhariwal A; Manjaly JG; Patel B; Morris-Jones S; David K; Khetarpal P; Beale T; Mehta N; Logan S
    J Int Adv Otol; 2023 Jun; 19(3):223-227. PubMed ID: 37272640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necrotising otitis externa in the immunocompetent patient: case series.
    Unadkat S; Kanzara T; Watters G
    J Laryngol Otol; 2018 Jan; 132(1):71-74. PubMed ID: 29173202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic criteria and therapy of malignant external otitis].
    Crovetto de la Torre MA; Fiz Melsio L; Grande Icaran D
    Acta Otorrinolaringol Esp; 1996; 47(3):175-80. PubMed ID: 8924279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of toxicity in patients with malignant otitis externa following long-term treatment with high dosage tobramycin.
    Ioannides-Demos LL; Li SC; Bastone EB; Spelman DW; Hooper RE; Cousins VC; McLean AJ
    J Antimicrob Chemother; 1994 Aug; 34(2):267-74. PubMed ID: 7814288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant external otitis: treatment with fluoroquinolones.
    Joachims HZ; Danino J; Raz R
    Am J Otolaryngol; 1988; 9(3):102-5. PubMed ID: 3177762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal variation of Pseudomonas aeruginosa in culture positive otitis externa in South East England.
    Villedieu A; Papesh E; Weinberg SE; Teare L; Radhakrishnan J; Elamin WF
    Epidemiol Infect; 2018 Oct; 146(14):1811-1812. PubMed ID: 29976272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
    Mekić S; Matanović K; Šeol B
    Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiology of otitis externa in the secondary care in United Kingdom and antimicrobial sensitivity.
    Ninkovic G; Dullo V; Saunders NC
    Auris Nasus Larynx; 2008 Dec; 35(4):480-4. PubMed ID: 18314283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pseudomonas and acute external otitis. Results of a microbiological study in patients without previous antibiotic treatment].
    Pino Rivero V; Pantoja Hernández CG; González Palomino G; Mora Santos ME; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2007; 34(1):45-51. PubMed ID: 17405458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapsing malignant otitis externa successfully treated with ciprofloxacin.
    Morrison GA; Bailey CM
    J Laryngol Otol; 1988 Oct; 102(10):872-6. PubMed ID: 3199005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant otitis externa].
    Licea Puig M; Dieguez Tejada RR; Padrón Durán RS
    Rev Clin Esp; 1979 Apr; 153(1):45-7. PubMed ID: 111318
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
    Elies W
    Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis.
    Rubin J; Stoehr G; Yu VL; Muder RR; Matador A; Kamerer DB
    Arch Otolaryngol Head Neck Surg; 1989 Sep; 115(9):1063-9. PubMed ID: 2504254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
    Levenson MJ; Parisier SC; Dolitsky J; Bindra G
    Laryngoscope; 1991 Aug; 101(8):821-4. PubMed ID: 1865729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute external otitis as debut of acute myeloid leukemia - A case and review of the literature.
    Slengerik-Hansen J; Ovesen T
    Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():110-112. PubMed ID: 29447882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective review and multi-specialty, evidence-based guideline for the management of necrotising otitis externa.
    Hopkins ME; Bennett A; Henderson N; MacSween KF; Baring D; Sutherland R
    J Laryngol Otol; 2020 Jun; 134(6):487-492. PubMed ID: 32498757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.